Concentric Capital Strategies, LP Pacific Biosciences Of California, Inc. Transaction History
Concentric Capital Strategies, LP
- $2.38 Billion
- Q3 2024
A detailed history of Concentric Capital Strategies, LP transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 50,000 shares of PACB stock, worth $97,500. This represents 0.2% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$97,500% of portfolio
0.2%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PACB
# of Institutions
254Shares Held
228MCall Options Held
745KPut Options Held
1.23M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33.4MShares$65.1 Million0.54% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$46 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$45.6 Million6.35% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V820.3MShares$39.6 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$34.4 Million0.0% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $438M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...